Aptose Biosciences Inc. APTO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • CA • USD

Aptose Biosciences Inc. (APTO) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 10 Buy, 1 Hold.

APTO Analyst Ratings

Buy

Ratings

10 Buy

1 Hold

Based on 11 analysts giving stock ratings to Aptose Biosciences Inc. in the past 3 months

Rating breakdown

Buy

10 91%

Hold

1 9%

91%

Buy

10 analysts

Hold

1 analysts

Sell

0 analysts

People Also View

LBPH

Longboard Pharmaceuticals, Inc.

$59.98

+0.00%

CRVS

Corvus Pharmaceuticals, Inc.

CytomX Therapeutics, Inc.

$4.54

+3.42%

ASMB

Assembly Biosciences, Inc.

$29.44

+0.68%

SPRO

Spero Therapeutics, Inc.

$2.78

-0.36%

FBIOP

Fortress Biotech, Inc.

$13.37

-2.33%

GANX

Gain Therapeutics, Inc.

$1.89

+1.07%

Aptose Biosciences Inc. APTO NASDAQ

APTO Analyst Ratings

People Also View

Get Undervalued Stock Alerts